Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective ...

Retatrutide, an experimental drug by Eli Lilly, shows promising results in weight loss by targeting three hormones, ...

The proportion of obese Indians has risen from 25 per cent in 2013 to 40 per cent in 2023, highlighting the need for ...

A top NYC weight-loss doctor shared the surprising skin complication that he’s encountered in patients using GLP-1 drugs like ...

Ready to crush your New Year’s health goals? These breakthrough medications offer more than weight loss—they support your ...

Eli Lilly's experimental weight loss drug, retatrutide, has demonstrated encouraging results in helping obese adults lose weight.

Canadian public and private insurers have balked at covering certain medication for weight-loss, but that might change as the ...

IT’S become one of the most popular ways in the showbiz world to stay slim. But Katherine Ryan has hit back at claims she’s ...

“Ozempic babies” are making headlines ... Symptoms of Polycystic Ovary Syndrome (PCOS) may be improved while on tirzepatide. Known by the brand name Mounjaro, it’s been prescribed off ...

Opens in a new tab or window The shortage of the diabetes and obesity injectable tirzepatide (Mounjaro ... semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), and liraglutide (Victoza ...

Participants taking tirzepatide also lost more body weight than those taking glucagon-like peptide-1 (GLP-1) receptor agonists, which include drugs like Ozempic® and Wegovy®. Compounded ...

Eli Lilly's Tirzepatide Outshines Novo Nordisk's Semaglutide, Yet Brand Recognition Remains Strong for Novo's Products ...